Special Issue "Discovery of Marine-Derived Anticancer Agents"
A special issue of Marine Drugs (ISSN 1660-3397). This special issue belongs to the section "Marine Pharmacology".
Deadline for manuscript submissions: 29 February 2024 | Viewed by 3316
Special Issue Editor
Interests: anticancer agents in green algae; Immune checkpoin inhibitor-based cancer therapy; nanoparticle-based cancer gene therapy; mesanchymal stem cell-based gene therapy
Special Issue Information
Dear Colleagues,
Cancer is one of the deadliest diseases worldwide. Despite the therapeutic strategies achieved in recent decades, cancer remains a huge threat to human health and therefore it is important to develop innovative therapeutic strategies, including new drugs.
In recent years, many studies have indicated that marine-derived compounds exhibit anticancer properties, such as inhibiting cell growth and migration in vitro and in vivo. As many of these compounds are involved in several biological processes and interactions, they may have a more effective role in interacting with biological target sites and mediating distinct intracellular signaling pathways.
Our objective is to present these new marine sources as active molecules for cancer prevention and therapy and demonstrate their efficiency. As the Guest Editor of this Special Issue, I invite scientists from all over the world to submit reviews and original and conceptual research articles highlighting the use of marine resources as drugs for the treatment of cancer and their mechanisms of action.
Dr. Masaaki Tamura
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- anticancer
- anti-tumor
- anti-proliferation
- molecular targets
- marine biotechnology
- marine natural products
- isolation and structure elucidation
- drug discovery
